Richard E. Champlin
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Stem Cell Institute(PA)Cellular Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors(2020)2,049 cited
- → Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.(1997)1,257 cited
- → Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy(1997)1,153 cited
- → Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia(2004)1,056 cited
- → Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.(1998)927 cited
- Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.(2002)